ORAMED PHARMACEUTICALS INC. Accounts Payable
ORAMED PHARMACEUTICALS INC. (ORMP) had Accounts Payable of $374.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Current $374.00K.
- 2026-03-31: Accounts Payable, Current $481.00K.
- 2025-12-31: Accounts Payable, Current $443.00K.
- 2025-09-30: Accounts Payable, Current $560.00K.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $374.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $481.00K 10-Q · filed 2026-05-19 |
| 2025-12-31 | $443.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $560.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $715.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $509.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $789.00K 10-K · filed 2026-03-26 |
| 2023-12-31 | $551.00K 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |